ElevateBio is a technology driven company powering transformative cell and gene therapies today and for many decades to come.
The company has assembled industry-leading talent, built world-class facilities, and integrated diverse technology platforms necessary for rapid innovation and commercialization of cell, gene, and regenerative therapies. The company has built an initial technology stack, including gene editing, induced pluripotent stem cells, and protein, viral, and cellular engineering. At the center of the business model is ElevateBio BaseCamp, a centralized R&D and manufacturing company that offers research and development (R&D), process development (PD), and Current Good Manufacturing Practice (CGMP) manufacturing capabilities. The company is focused on increasing long-term collaborations with industry partners while also continuing to develop its own highly innovative cell and gene therapies. ElevateBio's team of scientists, drug developers, and company builders are redefining what it means to be a technology company in the world of drug development, blurring the line between technology and healthcare.
ElevateBio is headquartered in Cambridge, Mass, with ElevateBio BaseCamp located in Waltham, Mass.
Location: United States, Massachusetts, Waltham
Employees: 201-500
Total raised: $1.1B
Founded date: 2017
Investors 3
| Date | Name | Website |
| 18.05.2023 | MPM Capita... | mpmcapital... |
| - | BioImpact ... | bioimpactc... |
| - | EcoR1 Capi... | ecor1cap.c... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 25.05.2023 | Series D | $401M | - |
| 15.03.2021 | Series C | $525M | - |
| 31.03.2020 | Series B | $170M | - |
Mentions in press and media 37
| Date | Title | Description | Source |
| 05.02.2024 | Startup funding is falling in most major cities. So why is B... | Startups Startup funding is falling in most major cities. So why is Boston pulling ahead? Melia Russ... | businessin... |
| 26.10.2023 | Despite one of biotech's biggest fundraisings of the year, E... | Even with $401 million in the bank—thanks to one of the year’s largest biotech fundraisings—ElevateB... | fiercebiot... |
| 25.05.2023 | ElevateBio raises $401 million in year's largest biotech VC ... | ElevateBio, a Massachusetts-based developer of cell and gene therapies, raised $401 million in Serie... | axios.com/... |
| 24.05.2023 | SoftBank-backed biotech research firm ElevateBio raises $401... | ElevateBio said on Wednesday it had raised $401 million in a new funding round led by a fund run by ... | dealstreet... |
| 24.05.2023 | ElevateBio Lands $401M Series D | WALTHAM, MA, ElevateBio announced the closing of its $401 million Series D financing led by the Ay... | vcnewsdail... |
| 24.05.2023 | ElevateBio Raises $401M in Series D Financing | ElevateBio, a Waltham, MA-based technology company focused on powering the creation of life-transfor... | finsmes.co... |
| 18.04.2022 | Biotech's top 10 money raisers of 2021 | After a bustling, record-setting 2020 for private biotechs raising cash, the bar heading into 2021 w... | fiercebiot... |
| 17.12.2021 | The $100M+ Dollar Club of U.S. Startups: Massachusetts | Officially known as the Commonwealth of Massachusetts, the state is located in the North-Eastern par... | vcbay.news... |
| 18.03.2021 | ElevateBio Announces Chief Scientific Officer of Regenerativ... | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar 18, 2021-- ElevateBio, a cell and gene therapy technology com... | oaoa.com/n... |
| 16.03.2021 | ElevateBio collects $525M Series C | ElevateBio has raised $525 million in a round led by Matrix Capital Management, with participation f... | pitchbook.... |
Show more